Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the skin pharmacokinetics and tolerability of bimatoprost
Formulation A and Formulation B following 14 days of once daily topical administration in
male participants with androgenetic alopecia (AGA).